Telix Pharmaceuticals
TLX.AX
£12.40
Share price
-2.85%
Change (1 day)
90.64%
Change (1 year)
Categories
Telix Pharmaceuticals (TLX.AX) - P/B ratio
P/B ratio as of April 2025 : 15.3
According to Telix Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 11.0795.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Telix Pharmaceuticals - P/B ratio (from 2017 to 2024)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2024-12-31 | 14.7 | -33% |
| 2023-12-31 | 21.9 | -23.31% |
| 2022-12-31 | 28.6 | -97.21% |
| 2021-12-31 | > 1000 | 7532.09% |
| 2020-12-31 | 13.4 | 139.46% |
| 2019-12-31 | 5.60 | 108.8% |
| 2018-12-31 | 2.68 | 137.19% |
| 2017-12-31 | 1.13 |